MSN Labs launches Vigabatrin Powder for the treatment of Epilepsy

A therapeutic equivalent, the drug approved by the Drugs Controller General of India (DCGI)

272
MSN Labs launches Vigabatrin Powder for the treatment of Epilepsy

Last Updated on October 19, 2024 by The Health Master

Following the successful launch of its third generation anti-epileptic drug, BRIVANEXT, MSN Labs has launched another anti-epileptic and India’s first generic Vigabatrin Powder for Oral Solution under the brand name VIGANEXT.

A therapeutic equivalent, the drug approved by the Drugs Controller General of India (DCGI), is indicated for infantile spasms – monotherapy in infants 1 month to 2 years of age – and as adjunctive therapy for refractory complex partial seizures in patients 2 years of age and older who have responded inadequately to several alternative treatments.

Vigabatrin is recommended as the first-line therapy for infantile spasm, a form of epilepsy that affects 1 in 2,000 children.

Previously, the availability of Vigabatrin was wholly dependent on grey market imports, which were severely disrupted during the COVID-19 lockdowns, impacting thousands of patients.

Appreciating the scarcity of the medicine, MSN Labs reached out to DCGI for the necessary approval to serve epilepsy patients in India with an uninterrupted supply of affordable Vigabatrin.

Speaking on the launch, MSN group stated, “Besides being a remarkable addition to our ever-expanding product basket, this drug benefits the patients in India by expanding the choice of affordable therapeutic options available to them.”

VIGANEXT, available in 500 mg sachets with 30 sachets per pack, is manufactured at the company’s state-of-the-art USFDA and EU approved finished dosage manufacturing campus in Hyderabad.

A portable Hydrogen inhaler launched: Dual-use technology

Lupin launches generic Fenofibrate capsules for this ailment

Sun Pharma launches acne treatment cream

Dr Reddy’s Labs launches generic Ephedrine Sulfate injection

Sun Pharma launches drug to treat Plaque Psoriasis in Canada

Glenmark launches unique fixed dose combination drug for Diabetes

CDSCO gives nod to Cadila for the drug to treat hyperkalemia

Pharma Industry to depend on low cost Chinese APIs due to…

No retention or renewal fees after one time registration of ASU products

PCI issues further advisory to Pharmacy Colleges regarding salaries to Teachers

A woman doing illegal MTPs arrested: Haryana

International Conference on National Education Policy will be held at …

IPC adds new impurities and Reference Standards: Download the list

Drug alert: 36 out of 1061 samples declared as NSQ in October 2021

Latest Circulars by the Govt of India, Dept of Pharmaceuticals, Health…

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news